High Aldehyde Dehydrogenase Activity: A Novel Functional Marker of Murine Prostate Stem/Progenitor Cells
Open Access
- 28 May 2009
- journal article
- tissue specific-stem-cells
- Published by Oxford University Press (OUP) in The International Journal of Cell Cloning
- Vol. 27 (9) , 2220-2228
- https://doi.org/10.1002/stem.135
Abstract
We have shown previously that prostatic stem/progenitor cells can be purified from isolated prostate ducts, based on their high expression of the Sca‐1 surface antigen. We now report that high levels of aldehyde dehydrogenase (ALDH) activity are present in a subset of prostate epithelial cells that coexpress a number of antigens found on stem/progenitor cells of other origins (CD9, Bcl‐2, CD200, CD24, prominin, Oct 3/4, ABCG2, and nestin). Almost all of these cells expressing high levels of ALDH activity also express Sca‐1 and a third of them express high levels of this antigen. The cells with high levels of ALDH activity have greater in vitro proliferative potential than cells with low ALDH activity. Importantly, in an in vivo prostate reconstitution assay, the cells expressing high levels of ALDH activity were much more effective in generating prostatic tissue than a population of cells with low enzymatic activity. Thus, a high level of ALDH activity can be considered a functional marker of prostate stem/progenitor cells and allows for simple, efficient isolation of cells with primitive features. The elucidation of the role of ALDH in prostate stem/progenitor cells may lead to the development of rational therapies for treating prostate cancer and benign prostatic hyperplasia. STEM CELLS 2009;27:2220–2228Keywords
Funding Information
- University of Cape Town Staff Research Fund
- South African Medical Research Council
- National Institutes of Health (CA132641)
- New York State Department of Health, Amgen Inc.
- Center for Stem Cell Biology at the New York University School of Medicine
This publication has 70 references indexed in Scilit:
- Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon TumorigenesisCancer Research, 2009
- Implications of the Cancer Stem-Cell Hypothesis for Breast Cancer Prevention and TherapyJournal of Clinical Oncology, 2008
- CD133 expression is not restricted to stem cells, and both CD133+ and CD133– metastatic colon cancer cells initiate tumorsJournal of Clinical Investigation, 2008
- Retinoic acid induces prostatic bud formationDevelopmental Dynamics, 2008
- ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical OutcomeCell Stem Cell, 2007
- Co-expression of the toleragenic glycoprotein, CD200, with markers for cancer stem cellsBiochemical and Biophysical Research Communications, 2007
- Phenotypic characterization of human colorectal cancer stem cellsProceedings of the National Academy of Sciences, 2007
- Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cellsProceedings of the National Academy of Sciences, 2006
- RARγ is critical for maintaining a balance between hematopoietic stem cell self-renewal and differentiationThe Journal of Experimental Medicine, 2006
- Generation of a functional mammary gland from a single stem cellNature, 2006